Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats

Infection and Immunity

Volumn 79, Issue 12, 2011, Pages 4819-4827

  Lee, Jin Hyung ^a   Regmi, Sushil Chandra ^a   Kim, Jung Ae ^a   Cho, Moo Hwan ^a   Yun, Hyungdon ^a   Lee, Chang Soo ^b   Lee, Jintae ^a  

^a Yeungnam University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PHLORETIN; TRANSCRIPTOME; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPLE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIUM ADHERENCE; BIOFILM; CELL GROWTH; COLITIS; COLON MUCOSA; COMMENSAL ESCHERICHIA COLI; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPITHELIUM CELL; FIMBRIA; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPHAGE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; ANIMAL; CELL STRAIN HT29; CHEMICAL STRUCTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; GROWTH, DEVELOPMENT AND AGING; MALUS; MICROBIOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; BACTERIAL ADHESION; BIOFILMS; COLITIS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HT29 CELLS; HUMANS; MALUS; MOLECULAR STRUCTURE; PHLORETIN; RATS; TRINITROBENZENESULFONIC ACID;

EID: 84862908776     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05580-11     Document Type: Article

References (50)

1. Baba, T., et al. 2006. Construction of Escherichia coli K-12 in-frame, singlegene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:2006 0008.
2. Beloin, C., A. Roux, and J. M. Ghigo. 2008. Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. 322:249-289.
3. Blattner, F. R., et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.
4. Boyce, T. G., D. L. Swerdlow, and P. M. Griffin. 1995. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N. Engl. J. Med. 333:364-368.
5. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 78:206-209.
6. Calliste, C. A., et al. 2001. Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res. 21:3949-3956.
7. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
8. Davies, D. G., and C. N. Marques. 2009. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191:1393-1403.
9. Farfan, M. J., K. G. Inman, and J. P. Nataro. 2008. The major pilin subunit of the AAF/II fimbriae from enteroaggregative Escherichia coli mediates binding to extracellular matrix proteins. Infect. Immun. 76:4378-4384.
10. Figtree, G. A., et al. 2000. Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J. Am. Coll. Cardiol. 35:1977-1985.
11. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205.
12. Garo, E., et al. 2007. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin. Antimicrob. Agents Chemother. 51:1813-1817.
13. Gill, S. R., et al. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-1359.
14. Hansen, M. C., R. J. Palmer, Jr., C. Udsen, D. C. White, and S. Molin. 2001. Assessment of GFP fluorescence in cells of Streptococcus gordonii under conditions of low pH and low oxygen concentration. Microbiology 147:1383-1391.
15. Hentzer, M., et al. 2002. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148:87-102.
16. Hooper, L. V., and J. I. Gordon. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115-1118.
17. Jung, M., S. Triebel, T. Anke, E. Richling, and G. Erkel. 2009. Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 53:1263-1280.
18. Kappachery, S., D. Paul, J. Yoon, and J. H. Kweon. 2010. Vanillin, a potential agent to prevent biofouling of reverse osmosis membrane. Biofouling 26:667-672.
19. Kobayashi, N., A. Ikesue, S. Majumdar, and T. J. Siahaan. 2006. Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion. J. Pharmacol. Exp. Ther. 317:309-316.
20. Kolodkin-Gal, I., et al. 2010. D-Amino acids trigger biofilm disassembly. Science 328:627-629.
21. Kolter, R., and E. P. Greenberg. 2006. Microbial sciences: the superficial life of microbes. Nature 441:300-302.
22. Koo, H., et al. 2003. Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol. J. Antimicrob. Chemother. 52:782-789.
23. Lee, J.-H., M. H. Cho, and J. Lee. 2011. 3-Indolylacetonitrile decreases Escherichia coli O157:H7 biofilm formation and Pseudomonas aeruginosa virulence. Environ. Microbiol. 13:62-73.
24. Lee, J.-H., and J. Lee. 2010. Indole as an intercellular signal in microbial community. FEMS Microbiol. Rev. 34:426-444.
25. Lee, J., T. Bansal, A. Jayaraman, W. E. Bentley, and T. K. Wood. 2007. Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl. Environ. Microbiol. 73:4100-4109.
26. Lee, J., et al. 2008. Indole cell signaling occurs primarily at low temperatures in Escherichia coli. ISME J. 2:1007-1023.
27. Lesic, B., et al. 2007. Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog. 3:1229-1239.
28. Low, A. S., et al. 2006. Analysis of fimbrial gene clusters and their expression in enterohaemorrhagic Escherichia coli O157:H7. Environ. Microbiol. 8:1033-1047.
29. Nataro, J. P. 2005. Enteroaggregative Escherichia coli pathogenesis. Curr. Opin. Gastroenterol. 21:4-8.
30. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
31. Pratt, L. A., and R. Kolter. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-293.
32. Rasmussen, T. B., and M. Givskov. 2006. Quorum-sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Microbiol. 296:149-161.
33. Ren, D., J. J. Sims, and T. K. Wood. 2001. Inhibition of biofilm formation and swarming of Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone. Environ. Microbiol. 3:731-736.
34. Ren, D., et al. 2005. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl. Environ. Microbiol. 71:4022-4034.
35. Rendón, M. A., et al. 2007. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc. Natl. Acad. Sci. U. S. A. 104:10637-10642.
36. Rezk, B. M., G. R. Haenen, W. J. van der Vijgh, and A. Bast. 2002. The antioxidant activity of phloretin: the disclosure of a new antioxidant pharmacophore in flavonoids. Biochem. Biophys. Res. Commun. 295:9-13.
37. Ryu, J. H., and L. R. Beuchat. 2005. Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl. Environ. Microbiol. 71:247-254.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Sartor, R. B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-594.
40. Sasaki, M., et al. 2007. Invasive Escherichia coli are a feature of Crohn's disease. Lab. Invest. 87:1042-1054.
41. Stangl, V., et al. 2005. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J. Nutr. 135:172-178.
42. Strockbine, N. A., et al. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
43. Swidsinski, A., et al. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54.
44. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086.
45. Ten Hove, T., et al. 2001. Blockade of endogenous IL-18 ameliorates TNBSinduced colitis by decreasing local TNF-α production in mice. Gastroenterology 121:1372-1379.
46. Thapa, D., et al. 2008. Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-κB-dependent manner. J. Pharmacol. Exp. Ther. 327:353-364.
47. Uhlich, G. A., P. H. Cooke, and E. B. Solomon. 2006. Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl. Environ. Microbiol. 72:2564-2572.
48. Vikram, A., G. K. Jayaprakasha, P. R. Jesudhasan, S. D. Pillai, and B. S. Patil. 2010. Suppression of bacterial cell-cell signalling, biofilm formation and type III secretion system by citrus flavonoids. J. Appl. Microbiol. 109: 515-527.
49. Wood, T. K. 2009. Insights on Escherichia coli biofilm formation and inhibition from whole-transcriptome profiling. Environ. Microbiol. 11:1-15.
50. Yang, C. S., J. M. Landau, M. T. Huang, and H. L. Newmark. 2001. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21:381-406.